Puerto Rico Pharmaceutical Summit 2023

With global supply chains continuing to face massive disruptions, the need to create infrastructure and economic incentives for pharmaceutical companies doing business in Puerto Rico is apparent.

Porzio has partnered with industry-leading subject matter experts for a one day conference. The 2023 Puerto Rico Pharmaceutical Summit will bring together thought leaders, business executives, government representatives, and policy influencers who will provide exclusive insight on why pharmaceutical companies must consider Puerto Rico for their business operations and further the conversation on what must be done on the island to support this critical industry.

Click here to view the full agenda. 

Location:

Condado Vanderbilt Hotel
1055 Ashford Ave, San Juan, 00907, Puerto Rico

This complimentary event is sponsored by Porzio, Bromberg & Newman. Advance registration is required and capacity is limited. You will be notified if you are placed on the waitlist. 

Topics:

Please join us for an in-depth discussion on the state of pharmaceutical manufacturing in Puerto Rico including:

• State of the Pharmaceutical Industry in Puerto Rico
• Power in Puerto Rico – The Quest for Renewable Energy in Puerto Rico
• Understanding Industry Incentives: Puerto Rico's Competitive Advantage for the Life Sciences Industry
• Washington Policy and the Inflation Reduction Act: How It Changed the Pharmaceutical Industry Forever
• FDA Perspective: Brief Overview of Steps for Approval of Drugs for Use in the United States; Importation of Approved Drugs from Puerto Rico; and Selling Drug Products into Puerto Rico
• Pharmaceutical Licensing and Supply Chain: Navigating and Understanding Ever Changing Regulations to Avoid Distribution
• Navigating the Latest PBM Trends: Insights and Strategies for Success

Confirmed Speakers:

• The Honorable, Pedro Pierluisi, Governor of Puerto Rico
• Javier Aleman, DHL
• Carmen Andrade, Principal, Porzio, Bromberg & Newman, P.C.
• Ryan G. Christiansen, CCIM, President and Founder, Christiansen Commercial Real Estate
• Francisco E. Colón-Ramirez, Of Counsel, Porzio, Bromberg & Newman, P.C.
• Lucy Crespo, CEO, Puerto Rico Science, Technology & Research Trust
• Paul Edattel, Principal, Todd Strategy Group
• Frank Fazio, Principal and SVP, Porzio Licensing & Porzio, Bromberg & Newman, P.C. 
• Carlos Fontan, Director of the Puerto Rico Office of Incentives
• Isabel Hernández, CPA, Partner, Kevane Grant Thornton, LLP
• Dr. Satish Iduru, Founder, Learis KN Life Sciences
• Ana Izquierdo-Henn, Director of Incentives & Legal Counsel, DECA Analytics
• Sean Keveney, Deputy General Counsel, US Department of Health and Human Services
• Jonathan Levitt, Founding Partner, Frier Levitt
• Dara Levy, Director, Hyman Phelps & McNamara
• Matthew Ludowig, General Counsel, Empower Pharmacy
• Carlos Fernandez Lugo, Chair, Environmental, Energy and Land Use, McConnell Valdes, LLC
• Ivan Lugo, Executive Director, Induniv  
• Humberto Mercader, Deputy Secretary for Strategic Initiatives at the Puerto Rico Department of Economic Development and Commerce
• Manuel Cidre Miranda, Secretary of the Department of Economic Development and Commerce
• Juan L. Negron, Director of Public Policy, Merck
• Karla Palmer, Partner, Hyman Phelps & McNamara
• Joe Paparo, Principal, Porzio, Bromberg & Newman, P.C.
• Yandia Pérez, Executive Director, PRMA
• Stuart Portman, Senior Health Policy Advisor, US Senate Committee on Finance 
• Ivan Roman, Consultant, Puerto Rico Pharmaceutical Industry Association    
• Raquel Rivera, Attorney, Porzio, Bromberg & Newman, P.C. 
• Will Rosellini, President, CytoImmune Therapeutics
• Javier Rúa, Chief Public Policy Officer, Solar and Energy Storage Association of Puerto Rico
• Robert Salcedo, CEO, Ocyonbio
• Ella Woger-Nieves, CEO, Invest Puerto Rico